Vincent Bond to Breast Neoplasms
This is a "connection" page, showing publications Vincent Bond has written about Breast Neoplasms.
Connection Strength
1.023
-
Huang MB, Tiwari PB, ?ren A, Shelton MN, Brena D, Wu JY, Khan MB, Powell MD, Stiles JK, Johnson EL, Yan F, Yang L, Bond VC. Investigating SMR Peptide Interactions with Breast Cancer-Associated Proteins. Int J Mol Sci. 2025 Sep 11; 26(18).
Score: 0.412
-
Huang MB, Brena D, Wu JY, Roth WW, Owusu S, Bond VC. Novel secretion modification region (SMR) peptide exhibits anti-metastatic properties in human breast cancer cells. Sci Rep. 2022 08 01; 12(1):13204.
Score: 0.332
-
Huang MB, Gonzalez RR, Lillard J, Bond VC. Secretion modification region-derived peptide blocks exosome release and mediates cell cycle arrest in breast cancer cells. Oncotarget. 2017 Feb 14; 8(7):11302-11315.
Score: 0.227
-
Katkoori VR, Basson MD, Bond VC, Manne U, Bumpers HL. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial-to-mesenchymal transition in colon and breast cancers. Oncotarget. 2015 Sep 29; 6(29):27763-77.
Score: 0.052